Schizophrenia Clinical Trials
Schizophrenia clinical trials evaluate new treatments, behavioral therapies, and medications for schizophrenia. Corterve compiles actively recruiting Schizophrenia studies from the ClinicalTrials.gov registry so you can search by location and eligibility criteria. Participation is always voluntary and confidential. This information is educational and not medical advice — talk with a licensed clinician about whether a study is right for you.
Recruiting Schizophrenia studies
- A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)NCT07288567PHASE3Bristol-Myers SquibbSchizophreniaAnaheim, California
- A Study of Brenipatide in Adult Participants With SchizophreniaNCT07410507PHASE2Eli Lilly and CompanySchizophreniaLittle Rock, Arkansas
- iTBS to Enhance Social Cognition in People With PsychosisNCT06118268NANorthwell HealthSchizophreniaGlen Oaks, New York
- Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental IllnessNCT05491538NAVA Office of Research and DevelopmentSchizophreniaMinneapolis, Minnesota
- Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1NCT07853807NAWashington University School of MedicineSCHIZOPHRENIA 1 (Disorder)Irvine, California
- Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsNCT05648591PHASE4Vanda PharmaceuticalsSchizophreniaDothan, Alabama
- Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy ControlsNCT07680114NAUniversity of Wisconsin, MadisonSchizophreniaMadison, Wisconsin
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)NCT07101094Bristol-Myers SquibbSchizophreniaOrange, California
- Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With PsychotherapyNCT06835556NAVanderbilt University Medical CenterSchizophrenia DisordersNashville, Tennessee
- Relapse Prevention Trial Evaluating KarXT Treatment in SchizophreniaNCT07686263PHASE3Karuna Therapeutics, Inc., a Bristol Myers Squibb companySchizophreniaBentonville, Arkansas
- A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With SchizophreniaNCT07615426PHASE1Janssen Research & Development, LLCSchizophreniaGarden Grove, California
- Efficacy of NBI-1117568 in Preventing Relapse in Adults With SchizophreniaNCT07227818PHASE3Neurocrine BiosciencesSchizophreniaGarden Grove, California
Schizophrenia trials by state
Schizophrenia trials by metro
Frequently asked questions
- How do I find recruiting Schizophrenia clinical trials?
- Browse the actively recruiting Schizophrenia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Schizophrenia clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Schizophrenia clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.